Advancing Nanomedicine Through Genetics: In Honor of Professor Maria Gazouli for Her Longstanding Scientific Impact

Topic Information

Dear Colleagues,

Advancing nanomedicine through genetics represents a multidisciplinary scientific sector involving biology, genomics, pharmaceutical technology, and nanotechnology, as well as nanoscale engineering, to improve the prevention, diagnosis, and treatment of several diseases. By integrating genetic information with nanoscience, researchers can design and develop medicines with added value in targeting specific tissues, as well as subcellular or cellular organelles. This scientific research approach ameliorates medicines' effectiveness and reduces adverse drug reactions, particularly in illnesses such as cancer, cardiovascular disorders, and neurodegenerative diseases.

Furthermore, advanced drug delivery nanosystems support personalized medicine, where medicines are designed and developed specifically for an individual’s genetic profile. Advances in genomics, combined with stimulus-responsive nanosystems and bionanosensors, also improve the early detection and real-time monitoring of disease progression.

Maria Gazouli, a Professor of Biology–Genetics–Nanomedicine at the Medical School of the National and Kapodistrian University of Athens (NKUA), is a highly cited researcher working at the intersection of genetics and nanomedicine. Her research integrates biology with nanomedicine approaches—for instance, developing nanotechnology-based biosensor arrays to detect circulating cancer cells and designing targeted nanocarriers for therapeutic use—making her scientific work highly relevant to advancing nanomedicine through genetic and molecular science.

The Topic “Advancing Nanomedicine Through Genetics: In Honor of Professor Maria Gazouli for Her Longstanding Scientific Impact” provides a platform to publish both reviews and original research papers. Please join us in creating a diverse collection of articles for a variety of topics. We look forward to receiving your contributions.

Prof. Dr. Leonardo A. Sechi
Dr. Natassa Pippa
Topic Editors

Keywords

Participating Journals

Journal Name	Impact Factor	CiteScore	Launched Year	First Decision (median)	APC
Biophysica biophysica	1.8	2.6	2021	19.1 Days	CHF 1200	Submit
BioTech biotech	3.6	5.6	2012	20.7 Days	CHF 1800	Submit
Future Pharmacology futurepharmacol	2.7	-	2021	17.7 Days	CHF 1200	Submit
International Journal of Molecular Sciences ijms	5.6	10.0	2000	17.5 Days	CHF 2900	Submit
Molecules molecules	5.1	10.3	1996	15.6 Days	CHF 2700	Submit
Pharmaceutics pharmaceutics	6.9	12.5	2009	16.3 Days	CHF 2900	Submit
Sci sci	4.1	5.4	2019	28.2 Days	CHF 1400	Submit

Preprints.org is a multidisciplinary platform offering a preprint service designed to facilitate the early sharing of your research. It supports and empowers your research journey from the very beginning.

MDPI Topics is collaborating with Preprints.org and has established a direct connection between MDPI journals and the platform. Authors are encouraged to take advantage of this opportunity by posting their preprints at Preprints.org prior to publication:

1. Share your research immediately: disseminate your ideas prior to publication and establish priority for your work.
2. Safeguard your intellectual contribution: Protect your ideas with a time-stamped preprint that serves as proof of your research timeline.
3. Boost visibility and impact: Increase the reach and influence of your research by making it accessible to a global audience.
4. Gain early feedback: Receive valuable input and insights from peers before submitting to a journal.
5. Ensure broad indexing: Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.

Published Papers